Regulatory Guide
FDA Status of Common Research Peptides
A factual reference page covering approved pharmaceutical equivalents, related brand names, and what those approvals do and do not mean for research-grade products.
The Core Distinction
A pharmaceutical version of a compound may be FDA-approved even when the research-grade version is not. That approval applies to the specific drug product, its dosage form, its manufacturing pathway, and its labeled medical indication — not to every vial or every research supplier using the same molecule name.
OSYRIS products are not those pharmaceutical brands. They are research-grade compounds sold for laboratory research only. The table below is included for regulatory context, not as a claim of equivalence.
FDA Context Table
| Compound | FDA-Approved Equivalent | Brand Name | Indication |
|---|---|---|---|
| GLP-1 (S) / Semaglutide | Yes | Ozempic, Wegovy | T2D, Obesity |
| GLP-2 (T) / Tirzepatide | Yes | Mounjaro, Zepbound | T2D, Obesity |
| PT-141 / Bremelanotide | Yes | Vyleesi | HSDD |
| Sermorelin | Former (discontinued) | Geref | GH deficiency testing |
| Tesamorelin | Yes | Egrifta | HIV lipodystrophy |
| Thymosin Alpha 1 | Non-US (35+ countries) | Zadaxin | Immune indications |
What the Table Does Not Mean
FDA approval of a pharmaceutical equivalent does not automatically convert a research-grade product into a legal prescription drug, a compounded medication, or a therapeutically marketed product. It also does not remove the RUO framework that applies to research-only sales.
Compounds like retatrutide add another layer: promising clinical data may exist even before formal approval. That can matter for research interest and literature depth, but it is still not the same thing as FDA approval.
Featured Links
Browse the current certificate archive and download batch-specific COA documentation for the catalog.
Open → Regulatory Guide Research-Grade vs Pharmaceutical-GradeUse the quality-tier guide to understand why an approved drug and a research-grade compound are different product categories.
Read → Shop Collection Metabolic CollectionBrowse the incretin and metabolic compounds that most often raise questions about approved pharmaceutical parallels.
Browse →Questions
Common Questions
Does FDA approval of a pharmaceutical version make the research version legal?
No. The approval applies to the approved drug product and its regulated manufacturing pathway, not automatically to research-grade material sold under RUO terms.
Are OSYRIS products compounded drugs?
No. OSYRIS sells research-grade compounds for laboratory use. The catalog is not a compounding-pharmacy offering.
What is the difference between research-grade and pharmaceutical-grade?
Research-grade material is intended for laboratory use and analytically verified for research standards. Pharmaceutical-grade products are manufactured for human use under cGMP and release controls.
Why are some peptides FDA-approved and others not?
Approval depends on whether a sponsor has completed the clinical, manufacturing, and regulatory process for a specific drug product and indication.
Can a doctor prescribe OSYRIS products?
No. OSYRIS products are not sold as prescription pharmaceuticals.
What about GLP-3 (R) / retatrutide?
Retatrutide has advanced clinical data but is not FDA-approved as of April 6, 2026. That makes it a high-interest research compound, not an approved medication.
